Leatt (LEAT) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Q2 2024 revenues declined 18% year-over-year to $10.08 million, with U.S. sales up and international sales down, resulting in a net loss of $1.06 million or $(0.17) per basic share, compared to net income of $776,000 in Q2 2023.
Consumer direct sales rose 19% and dealer direct sales increased 14%, while distributor sales fell 33%.
New product launches, including a bicycle components portfolio, contributed to growth in product categories.
Operating expenses rose 27% in Q2, mainly due to higher salaries, marketing, and lower bad debt recovery.
Inventory digestion is ongoing, with positive trends in ordering patterns expected to support future revenue growth.
Financial highlights
Q2 2024 global revenues were $10.08 million, down 18% year-over-year, with gross profit at $3.92 million (39% margin), down from $5.34 million (43% margin) in Q2 2023.
U.S. sales rose to $3.73 million, while international sales fell to $6.34 million.
Cash and cash equivalents increased to $13.33 million as of June 30, 2024, up from $11.35 million at year-end 2023.
Cash flows from operations for the first six months were $2.99 million, despite lower revenues and higher costs.
No advances were made on the $1.5 million revolving line of credit, which remains fully available.
Outlook and guidance
Management anticipates revenue growth as inventory levels normalize and new distributor partnerships mature.
Expects improved margins with the introduction of new product lines and reduced need for promotional activity.
Positive outlook for upcoming global launches in Moto, MTB, and ADV product lines.
Current cash and cash equivalents, along with operating cash flow, are expected to meet operating needs for at least the next twelve months.
Management expects continued impact from elevated industry inventory levels, global economic fragility, and foreign exchange volatility.
Latest events from Leatt
- 41% revenue growth and 248% net income increase highlight robust 2025 performance.LEAT
Q4 202524 Mar 2026 - Directors and auditors were approved by strong majorities, with no shareholder questions.LEAT
AGM 20243 Feb 2026 - Q3 2024 saw modest revenue growth and margin gains, but net income fell sharply.LEAT
Q3 202418 Jan 2026 - Q4 revenue up 14% and margins improved, but full-year sales and profit declined.LEAT
Q4 202425 Dec 2025 - Annual meeting to elect directors and ratify auditors, with focus on governance and transparency.LEAT
Proxy Filing2 Dec 2025 - Annual meeting set for July 1, 2025, to elect directors and ratify the auditor.LEAT
Proxy Filing2 Dec 2025 - Q1 2025 revenue up 45%, net income positive, global sales and margins drive growth.LEAT
Q1 202525 Nov 2025 - Q2 2025 revenue up 61%, net income up 208%, with robust growth and improved margins.LEAT
Q2 202524 Nov 2025 - Directors and auditor were elected and ratified with strong shareholder support.LEAT
AGM 202520 Nov 2025